Diabetic retinopathy is a leading cause of adult blindness in the United States. Up to 85% of patients with diabetes will develop diabetic retinopathy. When detected early, the progression of diabetic retinopathy can be retarded, decreasing rates of blindness and cost of treatment. Screening for DR is a HEDIS requirement, yet less than 1/3 of diabetics are compliant with this important guidance.
CarePortMD is proud to offer the first FDA-cleared Autonomous Artificial Intelligence-powered diagnostic screen for DR. Now this service can be scheduled at participating pharmacy locations across Delaware, Maryland, Pennsylvania and New Jersey!